Baird Medical's Advanced Microwave Ablation Solutions Captivate Attendees at the 2024 ATA Meeting
Baird Medical (BDMD) showcased its microwave ablation (MWA) technology at the 2024 American Thyroid Association Annual Meeting, drawing significant international attention. The event featured presentations by notable experts, including Dr. Emad Kandil from Tulane University and Dr. Feng Han from Sun Yat-sen University Cancer Center. Dr. Kandil presented clinical data demonstrating MWA's success in cases where RFA failed, emphasizing its safety and effectiveness for thyroid nodule treatment. Dr. Han shared insights on advanced procedural techniques and energy management based on his extensive experience with MWA procedures. The event concluded with hands-on demonstrations of Baird's technology.
Baird Medical (BDMD) ha presentato la sua tecnologia di ablazione a microonde (MWA) all'Annual Meeting 2024 dell'American Thyroid Association, attirando notevole attenzione internazionale. L'evento ha visto la partecipazione di esperti di rilievo, tra cui il Dr. Emad Kandil dell'Università di Tulane e il Dr. Feng Han del Sun Yat-sen University Cancer Center. Il Dr. Kandil ha presentato dati clinici che dimostrano il successo della MWA in casi in cui la RFA ha fallito, sottolineando la sua sicurezza ed efficacia nel trattamento dei noduli tiroidei. Il Dr. Han ha condiviso approfondimenti sulle tecniche procedurali avanzate e sulla gestione dell'energia, basati sulla sua vasta esperienza con le procedure MWA. L'evento si è concluso con dimostrazioni pratiche della tecnologia di Baird.
Baird Medical (BDMD) mostró su tecnología de ablación por microondas (MWA) en la Reunión Anual 2024 de la Asociación Americana de Tiroides, atrayendo una significativa atención internacional. El evento presentó ponencias de expertos destacados, incluyendo al Dr. Emad Kandil de la Universidad de Tulane y al Dr. Feng Han del Centro Oncológico de la Universidad Sun Yat-sen. El Dr. Kandil presentó datos clínicos que demostraron el éxito de la MWA en casos donde la RFA falló, enfatizando su seguridad y eficacia para el tratamiento de nódulos tiroideos. El Dr. Han compartió ideas sobre técnicas de procedimiento avanzadas y manejo de energía, basado en su amplia experiencia con procedimientos de MWA. El evento concluyó con demostraciones prácticas de la tecnología de Baird.
베어드 메디컬 (BDMD)는 2024년 미국 갑상선 학회 연례 회의에서 마이크로파 절제 (MWA) 기술을 선보이며 국제적인 주목을 받았습니다. 이 행사에서는 툴레인 대학교의 에마드 칸딜 박사와 선양 대학교 암센터의 팽 한 박사 등 저명한 전문가들의 발표가 있었습니다. 칸딜 박사는 RFA 가 실패한 사례에서 MWA 의 성공을 입증하는 임상 데이터를 발표하며 갑상선 결절 치료에 대한 안전성과 효과성을 강조했습니다. 한 박사는 MWA 절차에 대한 폭넓은 경험을 바탕으로 고급 절차 기술 및 에너지 관리에 대한 통찰을 나누었습니다. 이 행사는 베어드 기술의 실습 시연으로 마무리되었습니다.
Baird Medical (BDMD) a présenté sa technologie d'ablation par micro-ondes (MWA) lors de la réunion annuelle 2024 de l'American Thyroid Association, attirant une attention internationale significative. L'événement a été marqué par des présentations d'experts éminents, notamment le Dr Emad Kandil de l'Université de Tulane et le Dr Feng Han du Centre de Cancérologie de l'Université Sun Yat-sen. Le Dr Kandil a présenté des données cliniques démontrant le succès de la MWA dans des cas où la RFA avait échoué, soulignant sa sécurité et son efficacité pour le traitement des nodules thyroïdiens. Le Dr Han a partagé des idées sur des techniques procédurales avancées et la gestion de l'énergie, en s'appuyant sur son expérience approfondie des procédures MWA. L'événement s'est achevé par des démonstrations pratiques de la technologie de Baird.
Baird Medical (BDMD) stellte seine Mikrowellenablationstechnologie (MWA) auf der Jahresversammlung 2024 der American Thyroid Association vor und zog damit erhebliches internationales Interesse an. Die Veranstaltung umfasste Vorträge von namhaften Experten, darunter Dr. Emad Kandil von der Tulane University und Dr. Feng Han vom Sun Yat-sen University Cancer Center. Dr. Kandil präsentierte klinische Daten, die den Erfolg von MWA in Fällen zeigen, in denen die RFA versagte, und betonte deren Sicherheit und Effektivität bei der Behandlung von Schilddrüsenknoten. Dr. Han teilte Erkenntnisse über fortgeschrittene Verfahrenstechniken und Energiemanagement basierend auf seiner umfangreichen Erfahrung mit MWA-Prozeduren. Die Veranstaltung endete mit praktischen Demonstrationen der Technologie von Baird.
- Clinical data demonstrated MWA's superiority over RFA in certain cases
- Strong international interest and attendance at the company's booth
- Expert endorsement from leading medical professionals
- None.
The company's booth was a highlight of the exhibition floor, drawing in a constant stream of visitors eager to learn about Baird's latest innovations. Attendees engaged with the company's representatives, explored demonstrations of MWA technology, and participated in insightful discussions about the clinical benefits and advancements in thyroid treatments.
A major highlight of Baird Medical's Expo Theater session, expertly led by Dr. Helmi Khadra from Houston Methodist Hospital, was an impactful presentation by Dr. Emad Kandil, Professor at Tulane University School of Medicine. Dr. Kandil's presentation featured valuable clinical data, highlighting a compelling patient case where MWA succeeded following an RFA failure. He also offered a comparative analysis of MWA and RFA, along with practical recommendations for clinical application. "MWA of thyroid nodules is a novel, safe, and effective method for treating appropriately selected benign and malignant thyroid nodules in adults and pediatric populations. It can provide advantages compared to other thermal ablation techniques," stated Dr. Kandil. The session concluded with a dynamic Q&A, fostering thought-provoking dialogue and underscoring the medical community's growing interest in MWA.
Building on Dr. Kandil's clinical insights, Dr. Feng Han expanded the discussion by focusing on advanced procedural techniques and energy management. An expert from Sun Yat-sen University Cancer Center with extensive experience performing thousands of MWA procedures, Dr. Han shared key strategies for optimizing patient outcomes through refined MWA practices. His presentation provided attendees with a unique perspective on enhancing treatment precision and efficiency, encouraging meaningful discussions with global physicians eager to integrate these techniques into their practice.
The Expo Theater session concluded with hands-on demonstrations where medical professionals interacted directly with Baird's MWA technology and posed detailed questions about its applications.
Baird Medical's participation at the ATA meeting underscored its dedication to contributing to advancements in thyroid treatment, highlighting its ongoing efforts to support the medical community and foster valuable connections on a global scale. The company remains focused on continuing these efforts and exploring opportunities to advance its role in innovative thyroid care solutions.
About Baird Medical
Baird Medical is a leading provider of minimally invasive microwave ablation (MWA) technology, offering advanced treatment solutions for conditions such as thyroid nodules, breast disease, uterine fibroids, and liver cancer. A publicly traded company on NASDAQ, Baird Medical is dedicated to enhancing patient care through precision, efficiency, and safety in its innovative medical devices. For more information, please visit https://bairdmed.com/
View original content to download multimedia:https://www.prnewswire.com/news-releases/baird-medicals-advanced-microwave-ablation-solutions-captivate-attendees-at-the-2024-ata-meeting-302294994.html
SOURCE Baird Medical LLC
FAQ
What did Baird Medical (BDMD) present at the 2024 ATA Meeting?
How did Dr. Kandil describe BDMD's microwave ablation technology for thyroid treatment?
What clinical evidence was presented for BDMD's microwave ablation technology?
